MYC and acute lymphoblastic leukemia: Decrease in c-Myc protein expression could be restored by the proteasome inhibitor MG132, which shows c-Myc degradation in B-ALL occurs through the ubiquitin-proteasome pathway (26) (Figure 1E, Figure S3B).